Bone loss is a major, frequent and often permanent comorbid medical complication of anorexia nervosa (AN) affecting over half of all women with this disease and resulting in debilitating fractures, yet there are few effective therapies. In this proposal, we will test the effectiveness of a sequential therapeutic regimen designed to specifically: 1) reverse insulin-like growth factor 1 deficiency, thereby stimulating bone formation, and 2) reduce bone breakdown, using a bisphosphonate, a medication that is effective at reversing bone loss.

Public Health Relevance

Anorexia nervosa affects from 0.5-1.0% of college-age women and is complicated by severe bone loss, with a reduction of bone mineral density (BMD) by at least 1.0 SD in over 90% and by at least 2.5 SD in over one- third of patients. Moreover, anorexia nervosa is associated with a 30% prevalence of fractures. Effective therapies for this complication are needed. This proposal addresses this important public health problem with a randomized, placebo-controlled study of promising therapies for bone loss in this population, which is resistant to traditional approaches.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Skeletal Biology Structure and Regeneration Study Section (SBSR)
Program Officer
Malozowski, Saul N
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Bredella, Miriam A; Fazeli, Pouneh K; Daley, Scott M et al. (2014) Marrow fat composition in anorexia nervosa. Bone 66:199-204
Faje, Alexander T; Fazeli, Pouneh K; Miller, Karen K et al. (2014) Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord 47:458-66
Fazeli, Pouneh K; Klibanski, Anne (2014) Determinants of GH resistance in malnutrition. J Endocrinol 220:R57-65
Phan, C M; Khalilzadeh, O; Dinkel, J et al. (2013) C-arm CT for histomorphometric evaluation of lumbar spine trabecular microarchitecture: a study on anorexia nervosa patients. Br J Radiol 86:20120451
Miller, Karen Klahr (2013) Endocrine effects of anorexia nervosa. Endocrinol Metab Clin North Am 42:515-28
Lawson, Elizabeth A; Donoho, Daniel A; Blum, Justine I et al. (2011) Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry 72:1546-51
Miller, K K (2011) Endocrine dysregulation in anorexia nervosa update. J Clin Endocrinol Metab 96:2939-49
Miller, Karen K; Meenaghan, Erinne; Lawson, Elizabeth A et al. (2011) Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 96:2081-8
Fazeli, Pouneh K; Bredella, Miriam A; Misra, Madhusmita et al. (2010) Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab 95:407-13
Wojcik, Monica H; Meenaghan, Erinne; Lawson, Elizabeth A et al. (2010) Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone 46:796-800

Showing the most recent 10 out of 39 publications